Links between Alzheimer's disease and diabetes

Area of Science:

• Neuroscience
• Endocrinology
• Pharmacology

Background:

• Alzheimer's disease (AD) and diabetes mellitus (DM) are increasingly recognized as having potential links.
• Both conditions exhibit peripheral and central insulin abnormalities, impacting cognitive function and disease progression.
• Understanding shared pathogenesis is crucial for developing novel therapeutic strategies for AD and DM.

Purpose of the Study:

• To explore the intricate links between Alzheimer's disease and diabetes.
• To elucidate common pathogenic and pathophysiological mechanisms, particularly those involving insulin signaling and degradation pathways.
• To identify potential therapeutic targets for both neurodegenerative and metabolic disorders.

Main Methods:

• Review and synthesis of existing literature on the molecular and cellular mechanisms connecting AD and DM.
• Analysis of the role of insulin resistance in the context of AD pathogenesis.
• Investigation of the function and regulation of insulysin in relation to amyloid peptide and insulin degradation.

Main Results:

• Insulin resistance and impaired degradation of amyloid and insulin are central to the AD-diabetes link.
• Insulysin, an enzyme critical for degrading neurotoxic amyloid peptides and insulin, shows reduced function or expression in both AD and DM.
• Cognitive impairment is a common feature in diabetic patients, suggesting a direct impact of metabolic dysregulation on brain function.

Conclusions:

• The interplay between insulin signaling abnormalities and neurodegeneration is a key factor in AD.
• Therapeutic strategies targeting insulin effectiveness and enhancing insulysin activity warrant intensive investigation for AD treatment.
• Establishing definitive links and mechanisms could revolutionize pharmacological approaches for both Alzheimer's disease and diabetes.